Loading...
Pneumocystis jirovecii Pneumonia during Brentuximab Vedotin Therapy: A Case Report and Literature Review
Brentuximab vedotin (BV), an antibody drug conjugate against CD30, has been increasingly used in clinical practice, and the less common adverse events associated to the drug are not well described. Also, opportunistic infections have been reported, and data on immune reconstitution after use of BV a...
Na minha lista:
| Udgivet i: | Case Rep Hematol |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Hindawi
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6458937/ https://ncbi.nlm.nih.gov/pubmed/31049233 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/8982937 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|